Resmed Inc(RMD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 23 at 6:11 PM ET (Korea 10/24 07:11)
Full metrics table
| Index | S&P 500 | P/E | 24.23 | EPS (ttm) | 10.44 | Insider Own | 0.94% | Shs Outstand | 144.2M | Perf Week | 5.81% |
| Market Cap | 35.56B | Forward P/E | 19.01 | EPS next Y | 9.97% | Insider Trans | -2.86% | Shs Float | 139.3M | Perf Month | 13.96% |
| Enterprise Value | 34.92B | PEG | 2.06 | EPS next Q | 2.69 | Inst Own | 74.75% | Short Float | 9.18% | Perf Quarter | 24.51% |
| Income | 1.52B | P/S | 6.29 | EPS this Y | 8.32% | Inst Trans | 0.79% | Short Ratio | 9.72 | Perf Half Y | 15.01% |
| Sales | 5.65B | P/B | 5.54 | EPS next 5Y | 9.24% | ROA | 17.77% | Short Interest | 12.78M | Perf YTD | 4.98% |
| Book/sh | 45.66 | P/C | 24.15 | EPS past 3/5Y | 19.66% 26.34% | ROE | 24.27% | 52W High | -8.94% ($277.67) | Perf Year | -4.67% |
| Cash/sh | 10.47 | P/FCF | 21.56 | Sales past 3/5Y | 10.21% 12.08% | ROIC | 21.39% | 52W Low | 40.27% ($180.26) | Perf 3Y | 72.45% |
| Dividend Est. | $2.66 (1.05%) | EV/EBITDA | 16.11 | EPS Y/Y TTM | 9.65% | Gross Margin | 60.25% | Volatility(W/M) | 2.61% 2.24% | Perf 5Y | -5.47% |
| Dividend TTM | 2.46 | EV/Sales | 6.18 | Sales Y/Y TTM | 9.85% | Oper. Margin | 34.01% | ATR (14) | 5.74 | Perf 10Y | 296.83% |
| Dividend Ex-Date | 2026/8/20 | Quick Ratio | 2.42 | EPS Q/Q | 2.42% | Profit Margin | 26.94% | RSI (14) | 77.19 | Recom | 2.07 |
| Dividend Gr. 3/5Y | 10.89% 9% | Current Ratio | 3.1 | Sales Q/Q | 8.58% | SMA20 | 8.62% ($232.79) | Beta | 0.76 | Target Price | $261.68 |
| Payout | 23.01% | Debt/Eq | 0.13 | Earnings | 2026/10/29 | SMA50 | 10.16% ($229.54) | Rel Volume | 0.78 | Prev Close | $253.06 |
| Employees | 11370 | LT Debt/Eq | 0.08 | EPS/Sales Surpr. | 1.98% 0.16% | SMA200 | 12.34% ($225.08) | Avg Volume(3M) | 1.32M | Price | $252.86 |
| IPO | 1995/6/2 | Option/Short | Yes/Yes | Trades | 15397 | Volume | 1,032,416 | Change | -0.08% |
A global medical device company specializing in software-based digital health solutions for sleep apnea and respiratory diseases. Founded in 1989 in Sydney, Australia, the company is headquartered in California, USA, and serves as a key part of a global respiratory medical device group, supplying CPAP devices, masks, and respiratory equipment for sleep apnea (OSA) as well as chronic care software.
Over the past 1 year, roughly in the middle
9% below its 1-year high.
Traded less than usual. That is 78% of its average volume.
Next earnings report: October 29
3 days to go.
RMD makes money exceptionally well
Of every $100 in sales, $34.01 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +8.3% this year.
Tap to view numbers
The price is about the industry average
For a company expected to earn $100 next year, you would pay $1,901. Peers typically go for $1,968. Compared with its own 5-year average, it is 23% cheaper now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -5.5%. The S&P 500 did +68% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 1.05% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 74.8%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #4 of 50 in the industry
Based on market cap of $36B.
FAQ
What kind of company is RMD?
RMD belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of RMD?
The market cap of RMD is approximately $35.6B, ranking 414 within its sector.
Does RMD pay dividends?
RMD has a dividend yield of approximately 1.05%, with an annual dividend of $2.66.
What is the P/E ratio of RMD?
RMD has a P/E ratio of approximately 24.2x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for RMD?
RMD has recorded a 52-week high of $277.67 and a low of $180.26.
